Kevin Church - 08 Jun 2021 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Vice President of Discovery
Signature
/s/ Glenna Mileson, Attorney in fact for Kevin Church
Issuer symbol
ATHA
Transactions as of
08 Jun 2021
Net transactions value
+$3,278
Form type
4
Filing time
09 Jun 2021, 17:39:50 UTC
Previous filing
10 Jun 2021
Next filing
20 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATHA Common Stock Options Exercise $3,278 +3,152 +7.7% $1.04 44,133 08 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Options Exercise $0 -3,152 -100% $0.000000* 0 08 Jun 2021 Common Stock 3,152 $1.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option fully vested on September 1, 2016.